Mode
Text Size
Log in / Sign up
N/A Completed N=591 Randomized Treatment

Hypertension Intervention Nurse Telemedicine Study (HINTS)

Source: ClinicalTrials.gov NCT00237692 ↗
Enrolled (actual)
591
Serious AEs
40.9%
Results posted
Dec 2014
Primary outcomePrimary: Estimated Percentage of Participants in Blood Pressure Control at Baseline — 61; 59; 53; 64 % of particpants w/ controlled BP

Summary

There are 65 million Americans and over 8.5 million veterans who have been diagnosed with hypertension; yet only 31% of all hypertensive patients have their blood pressure (BP) under effective control (less than 140/90 mm/Hg). Uncontrolled hypertension greatly increases the risk of cerebral vascular accidents, coronary artery disease, myocardial infarction, renal failure, congestive heart failure, and mortality. Despite the damaging impact of hypertension and the availability of well-defined therapies and widely accepted target values for BP, interventions to improve BP control have had limited success.

Outcome Measures

OutcomeResultp-value
PRIMARY
Estimated Percentage of Participants in Blood Pressure Control at Baseline
61; 59; 53; 64
PRIMARY
Estimated Percentage of Participants in Blood Pressure Control at 6 Months
58; 61; 65; 64
PRIMARY
Estimated Percentage of Participants in Blood Pressure Control at 12 Months
60; 73; 73; 69
PRIMARY
Estimated Percentage of Participants in Blood Pressure Control at 18 Months
62; 59; 64; 72
PRIMARY
Blood Pressure Averages Systolic & Diastolic
127.1; 125.0; 124.7; 122.8; 75.6; 74.9

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of uncontrolled hypertension,
  • prescribed a medication to lower blood pressure,
  • have a regular primary care physician at Durham VA Medical Center, and
  • be a veteran. For Sustainability portion the patient must have participated in an intervention arm of primary study.

Exclusion Criteria

  • Hospitalized in past 3 months for stroke,
  • heart attack,
  • surgery for blocked arteries,
  • diagnosed with metastatic cancer or treated with dialysis,
  • have a diagnosis of dementia or a hearing impairment which prevents them from being able to hear/speak on the telephone, and
  • creatinine serum lab which exceed 2.5.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00237692). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search